Pharmaceutical - Markets & Marketing, Vaccines

Filter

Popular Filters

1 to 25 of 32 results

Sanofi Pasteur wins order for IPV from UNICEF, cutting price to $1 per dose

28-02-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, says that UNICEF, the organization…

GlobalMarkets & MarketingPharmaceuticalPricingSanofiSanofi PasteurVaccines

Modest growth expected for hepatitis B vaccine market

Modest growth expected for hepatitis B vaccine market

12-02-2014

The global hepatitis B virus (HBV) vaccine market value will experience modest growth over the coming…

Anti-viralsDynavax TechnologiesHeplisavHexyonMarkets & MarketingPharmaceuticalSanofiSanofi Pasteur MSDVaccines

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

15-01-2014

Japanese drug major Astellas Pharma and partner UMN Pharma have announced promising summary results for…

Asia-PacificASP7374Astellas PharmaGastro-intestinalsIrribowMarkets & MarketingPharmaceuticalResearchUMN PharmaVaccines

Takeda to sell BIKEN varicella vaccine in Japan

Takeda to sell BIKEN varicella vaccine in Japan

15-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it has reached agreement with the Research Foundation…

Asia-PacificMarkets & MarketingPharmaceuticalTakeda PharmaceuticalsVaccines

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

18-11-2013

Despite being hampered both by apathy and resistance in recent years, the human papillomavirus (HPV)…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalV503VaccinesWomen's Health

Infectious disease treatments market driven by growth in middle-income to low-income countries

17-05-2013

The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

Adult vaccines market controlled by GSK and Merck

15-04-2013

The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

Japan's seasonal flu vaccines market analysis

16-01-2013

The Japanese influenza vaccine market is valued at around $702 million in 2012, according to a new report…

Anti-viralsAsia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalSanofiVaccines

H1N1 pandemic fears to maintain lofty US flu vaccination levels, says GlobalData

08-01-2013

US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic…

Anti-viralsGlobalMarkets & MarketingNorth AmericaPharmaceuticalVaccines

News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102

17-12-2012

US drug developer Lexicon Pharmaceuticals (Nasdaq: LXRX) saw its shares leap 9.1% to $2.04 in premarket…

DiabetesGastro-intestinalsLexicon PharmaceuticalsLX1033Markets & MarketingPharmaceuticalRegulationResearchSanofiSanofi PasteurTranzymeTZP-102Vaccines

Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis

11-12-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) has launched its Imojev vaccine against…

Asia-PacificImojevMarkets & MarketingPharmaceuticalSanofiSanofi PasteurVaccines

CREW files motion to quash Sanofi Pasteur subpoena

06-12-2012

Washington DC, USA-based non-profit legal watchdog group Citizens for Responsibility and Ethics (CREW)…

LegalMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

Novartis' flu vaccines suspended in several countries on suspected quality issues

29-10-2012

A number of European Union member states have halted the use, as a precautionary measure, of some anti-influenza…

AgrifluAgrippalEuropeFluadMarkets & MarketingNorth AmericaNovartisPharmaceuticalRegulationVaccines

GSK's Synflorix to be used for GAVI pneumococcal vaccines program in Pakistan

10-10-2012

World's largest pneumococcal mass vaccination program is expected to protect up to 4.8 million children…

Asia-PacificGlaxoSmithKlineHealthcareMarkets & MarketingPharmaceuticalSynflorixVaccines

Biological launches Japanese Encephalitis vaccine JEEV in India

13-09-2012

Austria's Intercell AG (VSE: ICLL) that its partner, the Indian vaccines and pharma company Biological…

Asia-PacificBiological E LtdBiotechnologyIntercellJEEVMarkets & MarketingPharmaceuticalVaccines

Eisai's Fycompa gets first EU launch, in UK; links with Sabine Vaccine Inst

13-09-2012

Japanese drug major Eisai (TYO: 4523) has announced the first European launch today of Fycompa (perampanel),…

EisaiFycompaMarkets & MarketingNeurologicalPharmaceuticalResearchTropical diseasesVaccines

European vaccines market forecast to grow to $12.05 billion in 2018

11-09-2012

As vaccine manufacturers increasingly tend to leverage on novel technologies, and potential late-stage…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalProductionVaccines

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season

17-07-2012

The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

New vaccine uptake drives market growth in India

10-07-2012

In India, the government-sponsored Universal Immunization Program procures vaccines at very low prices,…

Asia-PacificMarkets & MarketingPharmaceuticalVaccines

GlaxoSmithKline plans vaccines and cancer drugs production in Kazakhstan

06-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed a cooperation agreement with the government of…

EuropeGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalVaccines

US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers

21-03-2012

In the USA, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association…

CervarixGardasilMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalPricingSanofiSanofi PasteurVaccines

Panacea Biotec launches polio vaccine in Nigeria

23-02-2012

Panacea Biotec, India's leading vaccine manufacturer, celebrated the 63rd Indian Republic Day by launching…

Emzor PharmaMarkets & MarketingPanacea BiotecPharmaceuticalPolprotecRest of the WorldVaccines

First US cell-based flu vaccine plant

13-12-2011

Under a public-private partnership of the US Department of Health and Human Services and Novartis Vaccines…

Markets & MarketingNorth AmericaNovartisPharmaceuticalVaccines

Indian vaccine market targets $4.6 billion revenue by 2017, up from current $900 million

17-11-2011

The Indian vaccine market is currently estimated to be worth around $900 million and targets $4.6 billion…

Asia-PacificMarkets & MarketingPharmaceuticalResearchVaccines

1 to 25 of 32 results

Back to top